BioSapien Inc.
| Private company | |
| ISIN | 🆔 |
| Industry | Biotechnology |
| Founded 📆 | 2018 in New York City, New York, United States |
| Founder 👔 | Khatija Ali |
Number of locations | |
Area served 🗺️ | |
Key people |
|
| Products 📟 | MediChip |
| Members | |
Number of employees | |
| 🌐 Website | biosapien |
| 📇 Address | |
| 📞 telephone | |
BioSapien Inc. is an biotechnology company founded in 2018, specializing in localized cancer treatment. The company is headquartered in New York City, United States, with operations in Abu Dhabi, United Arab Emirates.[1][2]
History
BioSapien was founded in 2018 by Khatija Ali in New York City. The company was initially focused on developing methods to improve localized cancer treatment. In its early development phase, BioSapien secured US$250,000 in pre-seed funding from private investors and accelerator programs, including RebelBio, backed by SOSV.[3]
In November 2021, BioSapien completed a seed funding round led by SOSV. Co-investors in the round included Hikma Ventures (subsidiary of Hikma Pharmaceuticals), Microventures, Infinity Capital Ventures, JPIN VCATS, and Side Door Ventures. The company raised US$2.1 million.[4][5]
In December 2021, BioSapien announced a partnership agreement with Vosfox Medical.[6]
In October 2023, BioSapien joined Hub71, a technology ecosystem based in Abu Dhabi, which was launched in 2019 by the government of the United Arab Emirates.[7]
In December 2024, BioSapien raised US$7 million[8][9] in a funding round led by Global Ventures, Golden Gates Ventures, and Dara Holdings.[10][11]
Products
BioSapien's main product is MediChip, a 3D-printed drug delivery device developed for localized chemotherapy.[1] The platform is designed to be implanted near tumor sites, enabling controlled and sustained release of therapeutic agents with the aim of reducing systemic exposure and related side effects. The technology uses customizable 3D bioprinting techniques to tailor treatment to individual patient needs.[1]
In addition to MediChip, the company holds several patents related to biomaterial-based drug delivery and tissue engineering. These include drug-eluting surgical materials and bioengineered constructs intended for use in vascular grafts and regenerative medicine. The patented technologies are designed to allow for precise drug diffusion and localized therapeutic application.[12]
Awards and recognition
In 2020, BioSapien's founder and CEO was included in a list of leading executives in the biotechnology sector.[13] In 2024, the company received recognition at the Make it in the Emirates startup pitch competition in the category of additive manufacturing for 3D printing.[14][15][16] That same year, BioSapien was acknowledged in a biotechnology leadership award program.[17]
External links
References
- ↑ 1.0 1.1 1.2 "MediChip Aims to Deliver Localized Cancer Treatment". MD+DI Online. Informa. Retrieved 2025-03-07.
- ↑ "From Philosophy to Cancer: The Unusual Story of Khatija Ali and BioSapien". AD SME Hub. Abu Dhabi SME Hub. Retrieved 2025-03-07.
- ↑ "Can One Innovative Idea Redefine Cancer Therapy? Dr. Khatija Ali Believes It's Possible". SME10X. SME10X Media. Retrieved 2025-03-07.
- ↑ "BioSapien Closes $1.8M Seed Round Led By SOSV & Hikma Ventures". Nasdaq Stock Exchange. Nasdaq Nordic. 2021-11-11. Retrieved 2025-03-07.
- ↑ "Hikma Ventures Invests in Biotechnology Company BioSapien Inc., Developer of a Patented Drug-Delivery Device Intended to Reduce the System-Wide Side Effects of Chemotherapy Treatments". Hikma Pharmaceuticals. Hikma Ventures. Retrieved 2025-03-07.
- ↑ "Vosfox Welcomes BioSapien as Our Customer". Vosfox Medical. Retrieved 2025-03-07.
- ↑ "BioSapien". Hub71. Hub71 Abu Dhabi. Retrieved 2025-03-07.
- ↑ "Biotech Startup BioSapien Raises USD 7M After Extending Pre-Series A Funding". Enterprise News. Enterprise UAE. Retrieved 2025-03-07.
- ↑ "BioSapien Extends Its Pre-Series A Round To US$7 Million". Inc. Arabia. Retrieved 2025-03-07.
- ↑ "Drug Delivery Platform BioSapien Raises $5.5M In Pre-Series A Funding Round". Forbes Middle East. Retrieved 2025-03-07.
- ↑ "UAE Biotech Startup BioSapien Raises $7 Million Pre-Series A For Cancer Treatment Platform". MENAbytes. 27 January 2025. Retrieved 2025-03-07.
- ↑ "Patents Assigned to BioSapien Inc". Justia Patents. Retrieved 2025-03-07.
- ↑ "Top 25 BioTech CEOs of 2020". Tech CEOs. Tech CEOs Magazine. 2020. Retrieved 2025-03-07.
- ↑ "Winners of 2nd Make it in the Emirates Startup Pitch Competition Announced". My Startup World. 31 May 2024. Retrieved 2025-03-07.
- ↑ "الإعلان عن الفائزين في مسابقة "اصنع في الإمارات للشركات الناشئة"". alwahdanews.ae. 30 May 2024. Retrieved 2025-03-07.
- ↑ "تكريم الفائزين بمسابقة «اصنع في الإمارات للشركات الناشئة»". Al-Ittihad (Emirati newspaper). Retrieved 2025-03-07.
- ↑ "BioSapien - Most Influential CEO Awards 2024 Winner". CEO Review. CEO Review Magazine. 2024. Retrieved 2025-03-07.
This article "BioSapien" is from Wikipedia. The list of its authors can be seen in its historical and/or the page Edithistory:BioSapien. Articles copied from Draft Namespace on Wikipedia could be seen on the Draft Namespace of Wikipedia and not main one.
